Table 1.
Demographic and clinical characteristics of the RA patients.
Table 2.
Internal consistency and item analysis of FN and PS.
Table 3.
Convergent validity of MDHAQ-C.
Table 4.
Discriminant validity of MDHAQ-C,with functional class and disease activity being the external anchor.
Table 5.
Correlations of RAPID3 and components with disease characteristics.
Figure 1.
Scatter plots of correlation between RAPID3 and DAS28 in 156 patients with Rheumatoid Arthritis (spearman's method).
Figure 2.
Scatter plots of correlation between RAPID3 and CDAI in 156 patients with Rheumatoid Arthritis (spearman's method).
Table 6.
The cross-tabulation of RAPID3 scores compared with DAS28 and CDAI in four categories.